Self-eumlsifying drug delivery system a novel approach for enhancement of bioavalibility

International Journal of PharmTech Research

Volumn 2, Issue 3, 2010, Pages 1738-1745

  Sachan, R ^a   Khatri, K ^a   Kasture, S B ^b  

^a VNS Institute of Pharmacy   (India)

^b Pinnacle Biomedical Research Institute   (India)

Author keywords

Co surfactant; Oil; Self emulsifying drug delivery system (SEDDS); Self micro emulsifying drug delivery systems (SMEDDS); Surfactant

Indexed keywords

ALPHA TOCOTRIENOL; HALOFANTRINE; OIL; PROGESTERONE; SILYMARIN; SOLVENT; SURFACTANT; UBIDECARENONE;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; EMULSION; IN VITRO STUDY; PARTICLE SIZE; REVIEW; SELF EMULSIFYING DRUG DELIVERY SYSTEM; THERMODYNAMICS; TURBIDIMETRY;

EID: 77957553216     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Stegemanna S, Leveillerb F, When poor solubility becomes an issue: from early stage to proof of concept, European Journal Pharmaceutical Science, 31, 2007, 249-61.
2. P.P. Bhatt, "Osmotic drug delivery systems for poorly soluble drugs," The Drug Delivery Companies Report Autumn/Winter 2004, 26-29 (PharmaVentures Ltd 2004)
3. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW: Self-emulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994; 106:15-23
4. R.N. Gursoy and S. Benita, "Self-emulsifying drug delivery systems for improved oral delivery of lipophilic drugs," Biomedicine and Pharmacotherapy 58, 2004, 173-182
5. Serajuddin A.T.M. Solid dispersion of poorly watersoluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88, 1999, 1058-1066.
6. Amidon GL, Lennernas H, Shah VP, Crison JR, A theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharmaceutical Research, 12, 1995, 413-420.
7. Patel PA, Chaulang GM, Akolkotkar A, Mutha SS, Handicap SR and Bhosale AV "Self Emulsifying Drug Delivery System: A Review" Research J. Pharm. and Tech. 1(4): Oct.-Dec. 2008, 313-323
8. R.N. Gursoy and S. Benita, "Self-emulsifying drug delivery systems for improved oral delivery of lipophilic drugs," Biomedicine and Pharmacotherapy 58, 2004, 173-182
9. P.P. Constantinides, "Lipid microemulsion for improving drugs dissolution and oral absorption: physical and biopharmaceutical aspects," Pharm Res. 12, 1995,1561-1572 10.
10. Khoo S.-M.; Humberstone A.J.; Porter C.J.H.; Edwards G.A.; Charman W.N."Formulation design and bioavailability assessment of lipidic silf-emulsifying formulation of halofanitrine," International Journal of Pharmaceutics, Volume 167, Number 1, 1 June 1998, 155-164
11. Carvajal MT, Patel CI, Infeld MH, Malick AW. Selfemulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994; 106: 15-23.
12. P.P. Constantinides, Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects, Pharm. Res. 1995; 12: 1561-1572.
13. J.R. Crison and G.L. Amidon, "Method and formulation for increasing the bioavailability of poorly water-soluble drugs," US Patent No. 5,993,858, issued November 30, 1999.
14. N. Farah, J.P. Laforet and J. Denis, "Self Micro Emulsifying Drug Delivery Systems for improving dissolution of drugs: In vitro evaluations," presented by Gattefosse Patented Technology at the AAPS Annual Meeting in San Diego, November 1994.
15. S. Nazzal and M.A. Khan, "Controlled release of a self-emulsifying formulation from a tablet dosage form: Stability assessment and optimization of some processing parameters," International Journal of Pharmaceutics 2006, 315, 110-121
16. H. Reiss, Entropy-induced dispersion of bulk liquids, J. Colloids Interface Sci. 1975; 53:61-70
17. T. Dabros, et al. Emulsification through area contraction, J.Colloids Interface Sci.1999; 210:222-230
18. S. Shafiq, S. Faiyaz, T. Sushma, J. A. Farhan, R. K. Khar and M. Ali,. Development and bioavailability assessment of ramipril nanoemulsion formulation Eur. J. Pharm. Biopharm 2007; 66: 227-243
19. Patil P, Joshi J, Paradkar. Effect of formulatiuon variables on preparation and evaluation of gelled self emulsifying drug delivery system (SEDDS) of ketoprofen. AAPS Pharm Sci Tech.2004; 5(3):34-42
20. Patil P., Vandana P., Paradkar P. formulation of selfemulsifying drug delivery system for oraldelivery of simvastatin:In vitro and in vivo evaluation. Acta pharma, 2007; 57: 111-122
21. T. Gershanik and S.Benita,"Positively-charged self-emulsifying oil formulation for improving oral bioavailability of progesterone," Pharm. Dev. Technol. 1996, 1, 147-157
22. Vergote GJ, Vervaet C, Van Driessche I, et al. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int J Pharm. 2001; 219:81-87
23. Yamada T, Onishi H, Machida Y. Sustained release ketoprofen microparticles with ethylcellulose and carboxymethylethylcellulose. J Control Release. 2001; 75:271-282
24. Roda A, Sabatini L, Mirasoli M, Baraldini M, Roda E. Bioavailability of a new ketoprofen formulation for once-daily oral administration. Int J Pharm. 2002; 241:165-172.
25. El-Kamel AH, Sokar MS, Al Gamal SS, Naggar VF. Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm. 2001; 220: 13-21
26. P.Gao, Enhanced oral bioavailability of a poorly water soluble drug PNU- 91325 by supersaturable formulations, Drug Dev.Ind.Pharm.2004; 30:221-229
27. Anand U. Kyatanwar, Kisan R. Jadhav, Vilasrao J. Kadam Self micro-emulsifying drug delivery system (SMEDDS): Review Journal of Pharmacy Research 2010, 3(1),75-83
28. T. Julianto, K.H. Yuen, A. Mohammad Noor, Improved bioavailability of vitamin E with a self emulsifying formulation, Int. J. Pharm. 2000; 200: 53-57.
29. Kommuru TR, Gurley B, Khan MA, Reddy IK Self-emulsifying drug delivery systems (SEDDS) of coenzymeQ10: formulation development and bioavailability assessment, Int. J. Pharm. 2001; 212: 233-246.
30. Catherine Tuleu, Michael Newton, Jayna Rose, Danielle Euler, Robert Saklatvala, Ashley Clarke, Steven Booth Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone, J. Pharm. Sci. 2004; 93: 1495- 1502.
31. S.P. Yap, K.H. Yuen, Influence of lipolysis and droplet size on tocotrienol absorption from selfemulsifying formulations, Int. J. Pharm. 2004; 281: 67-78
32. Hauss, D. J., S. E. Fogal, J. V. Ficorilli, C. A. Price, T. Roy, A. A. Jayaraj Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor, J. Pharm. Sci. 1998; 87: 164 169.
33. W. Wu, Y. Wang, L. Que, Enhanced bioavailability of silymarin by selfmicroemulsifying drug delivery system, Eur. J. Pharm. Biopharm. 2006; 63: 288-294. 315, 110-121